These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25275905)

  • 21. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in risk factors associated with ocular exfoliation syndrome.
    Ghaffari Sharaf M; Damji KF; Unsworth LD
    Acta Ophthalmol; 2020 Mar; 98(2):113-120. PubMed ID: 31736276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The composition of exfoliation material and the cells involved in its production.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S12-4. PubMed ID: 25275897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in LOXL1 associated with exfoliation glaucoma do not affect amine oxidase activity.
    Kim S; Kim Y
    Mol Vis; 2012; 18():265-70. PubMed ID: 22328822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The trabecular meshwork in normal eyes and in exfoliation glaucoma.
    Rasmussen CA; Kaufman PL
    J Glaucoma; 2014; 23(8 Suppl 1):S15-9. PubMed ID: 25275898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations.
    Elhawy E; Kamthan G; Dong CQ; Danias J
    Hum Genomics; 2012 Oct; 6(1):22. PubMed ID: 23157966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Wiggs JL; Pasquale LR
    J Glaucoma; 2014; 23(8 Suppl 1):S62-3. PubMed ID: 25275910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
    Thorleifsson G; Magnusson KP; Sulem P; Walters GB; Gudbjartsson DF; Stefansson H; Jonsson T; Jonasdottir A; Jonasdottir A; Stefansdottir G; Masson G; Hardarson GA; Petursson H; Arnarsson A; Motallebipour M; Wallerman O; Wadelius C; Gulcher JR; Thorsteinsdottir U; Kong A; Jonasson F; Stefansson K
    Science; 2007 Sep; 317(5843):1397-400. PubMed ID: 17690259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exfoliation syndrome: a disease with an environmental component.
    Dewundara S; Pasquale LR
    Curr Opin Ophthalmol; 2015 Mar; 26(2):78-81. PubMed ID: 25594763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
    Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
    Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoexfoliation syndrome and glaucoma: from genes to disease mechanisms.
    Schlötzer-Schrehardt U; Khor CC
    Curr Opin Ophthalmol; 2021 Mar; 32(2):118-128. PubMed ID: 33332884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of LOXL1 gene polymorphisms with exfoliation syndrome/glaucoma and primary open angle glaucoma in a Turkish population.
    Kasım B; İrkeç M; Alikaşifoğlu M; Orhan M; Mocan MC; Aktaş D
    Mol Vis; 2013; 19():114-20. PubMed ID: 23378724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
    Schlötzer-Schrehardt U
    Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy and Mitochondrial Dysfunction in Tenon Fibroblasts from Exfoliation Glaucoma Patients.
    Want A; Gillespie SR; Wang Z; Gordon R; Iomini C; Ritch R; Wolosin JM; Bernstein AM
    PLoS One; 2016; 11(7):e0157404. PubMed ID: 27391778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma.
    Holló G; Gál A; Kóthy P; Molnár JM
    J Glaucoma; 2011 Mar; 20(3):143-7. PubMed ID: 20436359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between LOXL1 and pseudoexfoliation.
    Wiggs JL
    Arch Ophthalmol; 2008 Mar; 126(3):420-1. PubMed ID: 18332326
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of microarray technology in deciphering the cause of genetic eye diseases: LOXL1 and exfoliation syndrome.
    Traboulsi EI; Sarfarazi M
    Am J Ophthalmol; 2008 Mar; 145(3):391-3. PubMed ID: 18282488
    [No Abstract]   [Full Text] [Related]  

  • 38. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
    Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
    Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States.
    Fingert JH; Alward WL; Kwon YH; Wang K; Streb LM; Sheffield VC; Stone EM
    Am J Ophthalmol; 2007 Dec; 144(6):974-975. PubMed ID: 18036875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.